Azelis announces deal with Rhodia for Aspirin in Europe
1 August 2005
The market-focused pan-European chemicals distribution group Azelis has announced an exclusive deal with Rhodia to distribute the company's acetylsalicylic acid (Aspirin) throughout Europe. From July 2005, Azelis will distribute Rhodia's Rhodine® brand using its European network.
Azelis was chosen for the exclusive distributorship deal because of the simple and effective structure of its pharmaceutical organisation, as well as its extensive network of warehousing that is compliant with European pharmaceutical legislation.
H U Wenzel, CEO of Azelis Group, says: “This is a very significant milestone in the realisation of the group’s ambition to become one of Europe’s leading specialty distributors. Rhodia is the number one producer of acetylsalicylic acid (Aspirin) for the merchant market as well as a world-wide leader in analgesic pharmaceutical ingredients.
The Rhodia aspirin products complement Azelis’s existing strong pharmaceutical range for both human and veterinary markets, giving our customers access to a full range of products to meet their needs. In addition, Azelis has extensive knowledge and experience in the pharmaceutical sector, supporting customers with technical knowledge and experience.”